Physician profile
William C James
NPI 1841291598
$221,910.56
in general payments reported to CMS, 2019-2025
19 companies · $36K in 2025
The $36K reported for 2025 was more than what 89% of Foot and Ankle Surgery providers received nationally (typical 2025 total: $1,200).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $23K · 2020: $20K · 2021: $35K · 2022: $41K · 2023: $41K · 2024: $27K · 2025: $36K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Royalty Or License: $93K · Acquisitions: $10K · Food and Beverage: $1,184.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Royalty Or License | $92,676.21 |
| Acquisitions | $10,029.23 |
| Food and Beverage | $1,184.22 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Extremity Medical | $132,243.20 | 2019-2025 | Omni, Omni Arch |
| Linvatec Corporation | $49,543.76 | 2022-2025 | Colink Afx, Colink Plating System, Avenger Radial Head, +4 Stems |
| In2bones USA, LLC | $37,968.52 | 2019-2022 | |
| Treace Medical Concepts, INC. | $485.81 | 2021-2022 | |
| Medline Industries LP | $298.09 | 2023-2024 | |
| Smith+Nephew, INC. | $296.71 | 2019-2024 | Pico, Acticoat 4" X 4", Renasys Touch |
| Peerless Surgical INC. | $277.54 | 2019-2025 | |
| Zyla Life Sciences, INC. | $170.33 | 2019 | |
| Acera Surgical, INC. | $153.60 | 2025 | Restrata Wound Matrix |
| Crossroads Extremity Systems, LLC | $125.00 | 2020 | |
| Depuy Synthes Sales INC. | $95.50 | 2023-2025 | Na, Fibulink, Motoband |
| Zimmer Biomet Holdings, INC. | $72.61 | 2019 | |
| Innovation Technologies INC | $45.66 | 2022-2023 | Irrisept |
| Heron Therapeutics, INC. | $36.60 | 2022 | |
| Averitas Pharma INC. | $31.67 | 2024 | Qutenza |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kci USA, INC. | $26.49 | 2022 | |
| Amniox Medical, INC. | $17.48 | 2019 | |
| Horizon Therapeutics Plc | $11.01 | 2019 | |
| Merck Sharp & Dohme LLC | $10.98 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William James listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.